Company profile for Arranta Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Arranta Bio is delivering on its vision to build the best-in-class microbiome contract development and manufacturing organization (CDMO) through our merger with a 10-year veteran CDMO, Captozyme, and the establishment of a commercial-ready manufacturing facility. Our aim is to support the pioneers in the development of healthcare therapies based on live biotherapeutic products (LBPs) targeting gut health and microbiome-related...
Arranta Bio is delivering on its vision to build the best-in-class microbiome contract development and manufacturing organization (CDMO) through our merger with a 10-year veteran CDMO, Captozyme, and the establishment of a commercial-ready manufacturing facility. Our aim is to support the pioneers in the development of healthcare therapies based on live biotherapeutic products (LBPs) targeting gut health and microbiome-related diseases by providing development and manufacturing services that bring effective treatments to the market and patients in need.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
650 Pleasant Street Watertown, MA 02472
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.recipharm.com/press-releases/statement-arranta-bio-settlement-thermo-fisher-litigation

PRESS RELEASE
05 Jun 2023

https://www.recipharm.com/press-releases/arranta-bio-recipharm-company-signs-contract-mit-develop-rapid-manufacturing-mrna-therapeutics#:~:text=Arranta%20Bio%2C%20part%20of%20Recipharm\'s,manufacturing%20technology%20for%20mRNA%20therapeutics.

PRESS RELEASE
28 Apr 2023

https://www.recipharm.com/press-releases/recipharms-arranta-bio-expands-rna-process-development-capacity-50-cent-meet-increased-customer-demand

PRESS RELEASE
09 Mar 2023

https://www.recipharm.com/press-releases/recipharm-completes-us-biologics-acquisitions

PRESS RELEASE
11 Apr 2022
Swedish CDMO Recipharm is absording Arranta Bio and Vibalogics
Swedish CDMO Recipharm is absording Arranta Bio and Vibalogics

19 Feb 2022

// Fraiser Kansteiner FIERCEPHARMA

https://www.fiercepharma.com/manufacturing/recipharm-working-moderna-s-covid-19-vaccine-boosts-biologics-arranta-bio-vibalogics

Fraiser Kansteiner FIERCEPHARMA
19 Feb 2022

https://www.contractpharma.com/contents/view_breaking-news/2021-11-16/arranta-bio-completes-sale-of-florida-site-to-inceptor-bio/?widget=listSection

CONTRACTPHARMA
16 Nov 2021

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty